FDA Inspection 977969 — US Naval Hospital Okinawa

US Naval Hospital Okinawa — FEI 3002809469

The FDA completed an inspection of US Naval Hospital Okinawa on Jun 15, 2016 in Ginowan City (Okinawa). The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 15, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ginowan City (Okinawa) (Japan)

Citations

IDCFRDescription
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
908921 CFR 600.14(c)When to report